Ultra Violette recalled 44,497 tubes of its Mini SPF Mates kit on August 22, 2025. The sunscreen products showed inconsistent SPF results, including readings as low as SPF 4. Consumers must stop use immediately and contact the distributor for guidance.
Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.
Consumers and healthcare providers should stop using this product immediately. Contact GRACE & FIRE PTY LTD or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the Ultra Violette Mini SPF Mates kit, which includes Velvet Screen SPF 50 and Supreme Sunscreen SPF 50. The products were distributed by Grace & Fire USA Inc. The lot numbers affected are A2453 and A2454, with expiration dates of November 30, 2026, and December 31, 2026.
Testing revealed the SPF 50 sunscreen's effectiveness varied greatly, with some tests showing SPF levels as low as 4. This inconsistency poses a significant risk to consumers relying on these products for sun protection.
There are no reported injuries or incidents associated with the recalled products at this time. However, the potential for inadequate sun protection is a serious concern.
Consumers should stop using the affected products immediately. For further guidance, contact GRACE & FIRE PTY LTD or consult your healthcare provider.
For more information, visit the FDA website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0641-2025. Consumers can also reach out to the distributor for assistance.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.